iDMT digital chemistry consortium with the University of Cambridge and AstraZeneca

Shionogi announced the Innovation Centre in Digital Molecular Technologies, an open consortium with the University of Cambridge and AstraZeneca for automated and digitalized chemical synthesis of molecules such as drugs. The release says the consortium aims to innovate chemistry practice by integrating high-throughput synthesis, analytics, chemical informatics, machine learning, robotics and reaction engineering.